Los puntos clave no están disponibles para este artículo en este momento.
SDMT is simpler to administer than PASAT3 and may be slightly more sensitive to MS cognitive impairment. It could thus be a suitable test to assess cognitive impairment routinely in people with relapsing-remitting multiple sclerosis.
López‐Góngora et al. (Sat,) studied this question.